Early Access Programmes: An Opportunity to Generate Early RWE & Share Experience
Time: 2:30 pm
day: Day 2
Details:
• Navigating compliance boundaries while collecting data within MAPs, learning from successes and overcoming key challenges
• Enhancing understanding of product safety by fulfilling mandatory safety reporting requirements
• Generating early real-world insights, sharing drug experience, and building advocacy through safety data analysis in EAPs
